Laird Norton Wetherby Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.72M Sell
5,312
-193
-4% -$60K 0.07% 255
2025
Q2
$2.14M Buy
+5,505
New +$2.21M 0.1% 208
2024
Q4
$2.33M Sell
6,304
-1,420
-18% -$594K 0.11% 177
2024
Q3
$4.02M Sell
7,724
-333
-4% -$178K 0.18% 96
2024
Q2
$4.37M Buy
8,057
+265
+3% +$140K 0.21% 76
2024
Q1
$4.04M Sell
7,792
-32
-0.4% -$15.9K 0.19% 94
2023
Q4
$3.69M Sell
7,824
-100
-1% -$46.2K 0.19% 99
2023
Q3
$3.45M Sell
7,924
-358
-4% -$162K 0.2% 93
2023
Q2
$3.68M Buy
8,282
+39
+0.5% +$18K 0.2% 91
2023
Q1
$3.79M Buy
8,243
+269
+3% +$128K 0.22% 84
2022
Q4
$4.09M Buy
7,974
+612
+8% +$311K 0.26% 71
2022
Q3
$3.34M Buy
7,362
+80
+1% +$38.3K 0.24% 75
2022
Q2
$3.51M Sell
7,282
-66
-0.9% -$32.7K 0.24% 76
2022
Q1
$3.61M Buy
7,348
+537
+8% +$245K 0.21% 91
2021
Q4
$3.16M Buy
6,811
+29
+0.4% +$12.2K 0.18% 103
2021
Q3
$2.53M Buy
6,782
+711
+12% +$270K 0.16% 121
2021
Q2
$2.32M Sell
6,071
-583
-9% -$223K 0.14% 134
2021
Q1
$2.39M Sell
6,654
-608
-8% -$196K 0.18% 105
2020
Q4
$2.33M Buy
7,262
+199
+3% +$61.1K 0.16% 124
2020
Q3
$1.9M Sell
7,063
-207
-3% -$55.7K 0.17% 118
2020
Q2
$1.91M Buy
7,270
+270
+4% +$72K 0.18% 112
2020
Q1
$1.59M Buy
7,000
+36
+0.5% +$9.81K 0.18% 114
2019
Q4
$2.1M Sell
6,964
-138
-2% -$38K 0.21% 109
2019
Q3
$1.71M Buy
7,102
+502
+8% +$138K 0.18% 131
2019
Q2
$1.86M Buy
6,600
+868
+15% +$237K 0.2% 114
2019
Q1
$1.65M Buy
5,732
+167
+3% +$48.3K 0.21% 109
2018
Q4
$1.46M Buy
5,565
+6
+0.1% +$1.65K 0.21% 113
2018
Q3
$1.52M Sell
5,559
-256
-4% -$66.5K 0.19% 116
2018
Q2
$1.38M Sell
5,815
-274
-4% -$63.5K 0.19% 118
2018
Q1
$1.34M Buy
6,089
+65
+1% +$15.3K 0.18% 117
2017
Q4
$1.36M Buy
6,024
+310
+5% +$66K 0.19% 119
2017
Q3
$1.08M Sell
5,714
-266
-4% -$50.6K 0.16% 144
2017
Q2
$1.13M Buy
5,980
+152
+3% +$27.3K 0.19% 121
2017
Q1
$964K Sell
5,828
-273
-4% -$43.4K 0.17% 136
2016
Q4
$877K Buy
6,101
+184
+3% +$24.6K 0.17% 136
2016
Q3
$741K Buy
5,917
+346
+6% +$44.7K 0.15% 167
2016
Q2
$732K Sell
5,571
-17
-0.3% -$2.33K 0.16% 147
2016
Q1
$776K Sell
5,588
-49
-0.9% -$6.55K 0.18% 123
2015
Q4
$786K Buy
5,637
+461
+9% +$63.5K 0.19% 119
2015
Q3
$724K Buy
5,176
+430
+9% +$64.6K 0.19% 120
2015
Q2
$779K Buy
4,746
+60
+1% +$9.59K 0.19% 114
2015
Q1
$723K Buy
4,686
+216
+5% +$30.8K 0.18% 121
2014
Q4
$562K Buy
4,470
+131
+3% +$16.2K 0.14% 166
2014
Q3
$519K Buy
4,339
+50
+1% +$5.74K 0.14% 173
2014
Q2
$462K Sell
4,289
-145
-3% -$14.9K 0.13% 191
2014
Q1
$441K Sell
4,434
-99
-2% -$8.95K 0.13% 205
2013
Q4
$419K Sell
4,533
-290
-6% -$25.8K 0.12% 213
2013
Q3
$403K Buy
4,823
+422
+10% +$36.2K 0.13% 200
2013
Q2
$361K Buy
+4,401
New +$329K 0.13% 189

Other funds holding ELV